New Blood Test for Heart Attacks Developed With Potentially Greater Sensitivity

Sep

Moving from Non-Invasive Prenatal Screening to Prenatal Diagnostics: An Expert Panel Discussion

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care.

Oct

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.

Menu

New Blood Test for Heart Attacks Developed With Potentially Greater Sensitivity

To read the full story....

Breaking News

Clear Labs Nanopore Sequencing Coronavirus Test Gets FDA Emergency Use Authorization

FDA Authorizes First COVID-19 Serology Test for Point-of-Care Use

United Airlines Launches COVID-19 Testing Program for Travelers to Hawaii

Babson Diagnostics Raises $13.7M In Series A Financing

FDA Grants Emergency Use Authorizations for Quadrant Biosciences, KimForest Coronavirus Tests

BARDA Awards $684K to Luminex for Enhanced COVID-19 Multiplex Antibody Test

Featured White Papers

Moving from Non-Invasive Prenatal Screening to Prenatal Diagnostics: An Expert Panel Discussion

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

What's Popular?

BioReference Settles False Claims, Kickback Allegations for $11.5M

UBS Downgrades Illumina to Neutral; Expresses Doubts About Grail Deal

Becton Dickinson Submits Premarket Approval Supplement to FDA for HPV Assay

FDA Grants Emergency Use Authorization for GK Pharmaceuticals Coronavirus Test

Grail Deal Will Enable Illumina to Expand From Tech Innovator to Diagnostics Provider

Sponsorships